FGL1

Global LAG-3 Inhibitor Market, Drug Sales, Price & Clinical Trials Insights Report 2023-2028: One of the Most Studied Immune Checkpoint After PD-1 and CTLA-4 - ResearchAndMarkets.com

Retrieved on: 
Friday, March 17, 2023

The "Global LAG-3 Inhibitor Market, Drug Sales, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global LAG-3 Inhibitor Market, Drug Sales, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering.
  • LAG-3 is an immune checkpoint and has been considered as a target for developing drugs and therapies for the treatment of cancer, chronic infectious diseases, and autoimmune diseases.
  • Future research also needs to focus on the effects of LAG-3 inhibition on other cells apart from the conventional T cells.
  • Number Of LAG-3 Inhibitor Drugs In the Market: 1 Drug
    Approved LAG-3 Inhibitor Drug Dosage, Patent & Pricing Insight
    Number Of LAG-3 Inhibitor Drugs In Clinical Trials: > 35 Drugs
    LAG-3 Inhibitor Drugs Clinical Trials Insight By Company, Country, Indication, & Phase

Global LAG-3 Inhibitor Market Research Report 2023: 1 Drug in the Market, 35 Drugs in Clinical Trials, LAG-3 Targeted Therapy Approaches, Competitive Landscape - Forecast to 2028

Retrieved on: 
Tuesday, March 7, 2023

DUBLIN, March 7, 2023 /PRNewswire/ -- The "Global LAG-3 Inhibitor Market, Drug Sales, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 7, 2023 /PRNewswire/ -- The "Global LAG-3 Inhibitor Market, Drug Sales, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering.
  • From these research studies, it is obvious that inhibition of immune cells by LAG-3 is both friend and foe.
  • Future research also needs to focus on the effects of LAG-3 inhibition on other cells apart from the conventional T cells.
  • Number Of LAG-3 Inhibitor Drugs In the Market: 1 Drug
    Approved LAG-3 Inhibitor Drug Dosage, Patent & Pricing Insight
    Number Of LAG-3 Inhibitor Drugs In Clinical Trials: > 35 Drugs
    LAG-3 Inhibitor Drugs Clinical Trials Insight By Company, Country, Indication, & Phase